Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Ovid Therapeutics Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 82 | +1 |
| Shares | 47.6M | 119.1K | 46.4M | −1.05M (−2.2%) |
| Value | $44.4M | $111.2K | $14.5M | −$29.8M (−67.3%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Ovid Therapeutics Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 667,516 | $208.2K | 0.03% |
| Squarepoint Ops LLC | 265,491 | $82.8K | 0.00% |
| Nuveen, LLC | 119,113 | $37.2K | 0.00% |
| XTX Topco Ltd | 93,154 | $29.1K | 0.00% |
| HRT Financial LP | 25,592 | $7.00K | 0.00% |
| Los Angeles Capital Management LLC | 15,681 | $4.89K | 0.00% |
| CIBC World Markets Corp | 13,068 | $4.08K | 0.00% |
| Abel Hall, LLC | 10,238 | $3.19K | 0.00% |
| True Wealth Design, LLC | 32 | $10 | 0.00% |
| GWM Advisors LLC | 4 | $1 | 0.00% |
Sold out (9)
Institutions that held Ovid Therapeutics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Siren, L.L.C. | 2,850,000 | $2.66M |
| UBS Oconnor LLC | 943,416 | $881.2K |
| Monimus Capital Management, LP | 138,266 | $129.1K |
| Jane Street Group, LLC | 14,278 | $13.3K |
| BBR Partners, LLC | 12,495 | $11.7K |
| DCF Advisers, LLC | 11,750 | $11.0K |
| Capital Advisors, Ltd. LLC | 1,710 | $2.00K |
| Russell Investments Group, Ltd. | 447 | $417 |
| Simplex Trading, LLC | 590 | $0 |
Not filed for Q1 2025 yet (1)
Institutions that held Ovid Therapeutics Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 119,113 | $111.2K |